1. Home
  2. CASS vs BBOT Comparison

CASS vs BBOT Comparison

Compare CASS & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

HOLD

Current Price

$56.00

Market Cap

714.9M

ML Signal

HOLD

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

HOLD

Current Price

$8.05

Market Cap

682.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASS
BBOT
Founded
1906
2016
Country
United States
United States
Employees
N/A
106
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.9M
682.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CASS
BBOT
Price
$56.00
$8.05
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$45.00
$24.00
AVG Volume (30 Days)
59.6K
342.0K
Earning Date
04-23-2026
05-26-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
N/A
EPS
0.67
N/A
Revenue
$190,750,000.00
N/A
Revenue This Year
$0.81
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$83.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$7.00
52 Week High
$56.69
$14.87

Technical Indicators

Market Signals
Indicator
CASS
BBOT
Relative Strength Index (RSI) 67.60 48.45
Support Level $51.00 $7.99
Resistance Level N/A $9.45
Average True Range (ATR) 1.43 0.53
MACD 0.12 -0.05
Stochastic Oscillator 77.55 27.02

Price Performance

Historical Comparison
CASS
BBOT

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Share on Social Networks: